Olodanrigan Uses, Dosage, Side Effects and more
Olodanrigan is under investigation in clinical trial NCT03297294 (Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN)).
| Trade Name | Olodanrigan |
| Generic | Olodanrigan |
| Olodanrigan Other Names | Olodanrigan |
| Type | |
| Formula | C32H29NO5 |
| Weight | Average: 507.586 Monoisotopic: 507.204573038 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
